Header cover image

South Korean (KOSPI) Healthcare Services Industry Analysis

UpdatedFeb 27, 2024
DataAggregated Company Financials
Companies10
  • 7D-6.5%
  • 3M17.4%
  • 1Y3.1%
  • YTD-0.7%

Last week, the Healthcare Services industry hasn't moved much but HLB Life Science is up 4.4% in that time. Furthermore, the industry has been flat for the past year as well.

Industry Valuation and Performance

Has the South Korean Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 27 Feb 2024₩3.2t₩1.3t-₩115,028,901,300.003.3x-27.6x2.4x
Thu, 25 Jan 2024₩14.7t₩3.5t-₩48,515,911,380.0013.3x-302.6x4.2x
Sat, 23 Dec 2023₩15.1t₩3.5t-₩48,515,911,380.0012.6x-311.3x4.3x
Mon, 20 Nov 2023₩13.8t₩3.5t-₩2,218,094,830.008x-6243.8x3.9x
Wed, 18 Oct 2023₩12.7t₩3.4t₩83.2b8.2x152.5x3.8x
Fri, 15 Sep 2023₩13.0t₩3.4t₩83.2b10.5x156.3x3.9x
Sun, 13 Aug 2023₩13.8t₩3.3t₩99.3b12.7x139.1x4.2x
Tue, 11 Jul 2023₩12.1t₩3.3t₩99.3b13.7x121.6x3.6x
Thu, 08 Jun 2023₩14.4t₩3.3t₩99.3b13.9x145.3x4.4x
Sat, 06 May 2023₩13.7t₩3.1t₩35.1b45.3x391.5x4.4x
Mon, 03 Apr 2023₩11.9t₩3.1t₩35.1b40.4x339.9x3.8x
Wed, 01 Mar 2023₩11.2t₩3.1t₩180.7b23x62x3.6x
Fri, 27 Jan 2023₩11.9t₩3.1t₩180.7b23.8x65.7x3.8x
Sun, 25 Dec 2022₩12.3t₩3.1t₩180.7b24.7x67.8x3.9x
Tue, 22 Nov 2022₩12.3t₩3.1t₩220.1b24.9x56x4x
Thu, 20 Oct 2022₩12.4t₩3.0t₩112.6b40.1x110.6x4.2x
Sat, 17 Sep 2022₩13.1t₩3.0t₩112.6b40.7x116.7x4.4x
Mon, 15 Aug 2022₩14.9t₩2.9t₩136.5b8.5x109.5x5.2x
Wed, 13 Jul 2022₩13.8t₩2.9t₩136.5b8.3x101.2x4.8x
Fri, 10 Jun 2022₩12.8t₩2.9t₩136.5b9.7x94.1x4.4x
Sun, 08 May 2022₩12.0t₩2.8t₩133.0b10.8x90.5x4.3x
Tue, 05 Apr 2022₩12.9t₩2.8t₩133.0b11.4x97.2x4.6x
Thu, 03 Mar 2022₩12.5t₩2.6t₩228.6b7.9x54.8x4.9x
Sat, 29 Jan 2022₩12.4t₩2.6t₩228.6b8.2x54.3x4.8x
Mon, 27 Dec 2021₩15.5t₩2.6t₩228.6b8.9x67.6x6x
Wed, 24 Nov 2021₩16.0t₩2.6t₩250.9b12.8x63.9x6.1x
Fri, 22 Oct 2021₩17.0t₩2.6t₩210.5b13.9x80.6x6.4x
Sun, 19 Sep 2021₩22.1t₩2.6t₩210.5b14.4x105.2x8.4x
Tue, 17 Aug 2021₩21.3t₩2.6t₩211.0b14x100.9x8.1x
Tue, 01 Jun 2021₩21.4t₩2.6t₩224.2b11x95.7x8.2x
Fri, 05 Mar 2021₩22.0t₩2.6t₩228.9b10.4x96.1x8.4x
Price to Earnings Ratio

96.1x


Total Market Cap: ₩22.0tTotal Earnings: ₩228.9bTotal Revenue: ₩2.6tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Healthcare Services Industry Price to Earnings3Y Average 19.9x202220232024
Current Industry PE
  • Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.2x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 21% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-0.86%
Healthcare1.80%
Healthcare Services-6.49%
Managed Healthcare0%
Healthcare Services-4.02%
Healthcare Distributors-5.87%
Healthcare Facilities-8.54%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A118000 SMEDI₩436.002.3%
+₩1.4b
-20.7%PS3.7x
A072520 GenNBio₩460.001.1%
+₩370.7m
-69.8%PS4.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A067630

₩14,270.00

HLB Life Science

7D

-6.3%

1Y

29.3%

A032940

₩3,910.00

Wonik

7D

-7.5%

1Y

-6.7%

A072520

₩460.00

GenNBio

7D

1.1%

1Y

-69.8%

A078160

₩7,150.00

MEDIPOST

7D

-3.4%

1Y

-53.5%

A085660

₩16,700.00

ChabiotechLtd

7D

-8.5%

1Y

20.1%

A221800

₩4,550.00

U2Bio

7D

-8.2%

1Y

-29.2%

A118000

₩436.00

SMEDI

7D

2.3%

1Y

-20.7%

A043710

₩680.00

SEOULEAGUER

7D

-2.0%

1Y

-13.0%

A299170

₩2,175.00

WSI

7D

-0.2%

1Y

7.1%